Medicaid: Adapt to the Changes
Avalere experts discuss an evolving Medicaid program supported by a new administration and novel state approaches.
Association Health Plans Projected to Enroll 3.2 Million Individuals
New analysis from Avalere finds that the proposed rule on association health plans (AHPs) is projected to lead to 3.2M enrollees shifting out of the Affordable Care Act's (ACA) individual and small group markets into AHPs by 2022.
Midwest and Mid-Atlantic States Face Provider Shortage to Address Opioid Epidemic
New research from Avalere Health finds 11 states and DC lack an adequate number of providers certified to prescribe buprenorphine, a medicine used to prevent relapse in people with opioid dependence.
Congress’ 2018 Budget Includes Updates for Providers
On February 9, the Senate voted to pass the Bipartisan Budget Act of 2018, which funds the government through March 23, lifts spending caps for 2 years, and suspends the debt ceiling until March 2019.
Our Take on the President’s FY2019 Budget Proposal
Today, the Trump Administration released its budget for fiscal year 2019 (FY 2019).
Impact of Coverage Gap Discount Changes in Budget Agreement
Avalere experts provide their insights on what the impact of coverage gap discount changes in budget agreement.
BPCI Advanced Provides a Glimpse into the Future of Bundled Payments
Last month, the Centers for Medicare & Medicaid Services (CMS) released a Request for Application (RFA) for the Bundled Payment for Care Improvement (BPCI) Advanced initiative.
Our Take on the 2019 Advance Notice and Draft Call Letter
Yesterday, the Centers for Medicare & Medicaid Services (CMS) released Part II of the Advance Notice and Call Letter (ANCL), describing the Agency's proposed 2019 payment policies and other policy updates for the upcoming plan year for Medicare Advantage (MA) and Part D plans.
BPCI Advanced: What Hospitals and Physicians Need to Know
With applications for the new Bundled Payment for Care Improvement (BPCI) Advanced initiative due on March 12, providers have a short window to act.
Avalere Analysis Shows that Health Needs and Cost of Medicaid Expansion Populations Grow over Time
Beneficiaries show signs of pent-up demand with acute healthcare needs early in their enrollment, but over time costs increase substantially and shift toward chronic care.
2018 Healthcare Industry Outlook
2018 will bring change from all parts of the healthcare system.
Our Take on the BPCI Request for Application Announcement
The Centers for Medicare & Medicaid Services (CMS) have released a Request for Application (RFA) for the Bundled Payments for Care Improvement (BPCI) Advanced Initiative.
Avalere Expands Actuarial and Data Analytics Expertise with Hire of Kenny Kan
Kenny Kan has joined the Avalere team leading the firm's actuarial analytics. Prior to joining Avalere, Kan served as the Chief Actuary at Humana and CareFirst.
2018 Healthcare Industry Outlook: Elevate Your Perspective
Avalere experts expand on significant priorities for 2018.
Gillian Woollett’s Research Published in BioDrugs
Gillian Wollett, Senior Vice President of Avalere’s FDA & Regulatory Policy team, recently published “A ‘Global Reference’ Comparator for Biosimilar Development” in BioDrugs.
Final 2018 Exchange Enrollment Numbers
At 100% of the OEP, we are at 96% of total Healthcare.gov enrollment compared to 2017 (8.8M n 2018 compared to 9.2M in 2017).
Avalere Develops Report on Opioid Analgesic Trends
Resource presents trends in opioid painkiller prescriptions and deaths due to misuse and abuse.
Avalere 2018 Healthcare Industry Outlook
Elevate your perspective to adapt to the 2018 healthcare environment. Watch a preview of moderator Caroline Pearson set the stage for our 2018 Healthcare Industry Outlook.
FDA Prepares for the Next Generation of Regenerative Medicines
In its new regulatory framework for regenerative medicines released in November 2017, FDA takes a flexible approach, creating opportunity for manufacturers.
California, North Carolina, and New York Will See the Largest Provider Payment Cuts and Beneficiary Savings Due to 340B Program Changes
Analysis also finds that 62% of impacted facilities will experience less than a 5% reduction in Medicare Part B revenue due to the drug cuts, but 6% of applicable hospitals will experience cuts greater than 10%.